Clinical trials recruiting in China
3,909
Recruiting trials
15
Conditions
498
Cities with sites
Phase breakdown
Early Phase 1 100Phase 1 618Phase 2 1148Phase 3 577Phase 4 113Not applicable 1695
Cities in China
Beijing 716Shanghai 708Guangzhou 606Shanghai 469Hangzhou 444Beijing 409Wuhan 307Nanjing 299Changsha 291Chengdu 275Zhengzhou 225Jinan 222Guangzhou 198Tianjin 176Hefei 171Shenyang 171Fuzhou 162Nanchang 160Chongqing 153Hangzhou 152Changchun 145Tianjin 139Wuhan 135Chengdu 132
Conditions recruiting in China
| Condition | Trials |
|---|---|
| Lung Cancer | 866 |
| BREAST CANCER | 594 |
| Colorectal Cancer | 388 |
| Pancreatic Cancer | 249 |
| Non Small Cell Lung Cancer | 243 |
| Prostate Cancer | 195 |
| Hypertension | 172 |
| Obesity | 169 |
| Lupus | 141 |
| Type 2 Diabetes | 124 |
| Depression | 109 |
| Heart Failure | 98 |
| Alzheimer s Disease | 96 |
| Chronic Kidney Disease | 88 |
| Atrial Fibrillation | 84 |
Recruiting trials in China
- "Real-life" Cohort Study on Patients With Chronic HBV Infection in Jiangsu
- "Smart Family Doctor" Assisted Comprehensive Management of Secondary Prevention Among Post Coronary Artery Bypass Graft Patients or Post Percutaneous Coronary Intervention Patients
- "Thymalfasin Immunotherapy Study with Triple Regimen in Advanced MSS/pMMR Colorectal Cancer"
- 177Lu-P17-087/177Lu-P17-088 in Patients With Metastatic Castration-resistant Prostate Cancer
- 18F-T2 PET/CT Imaging for CAIX Positive Solid Tumors
- 21-gene in Elder Breast Cancer Patients With Lymph Node Metastasis
- 3D-MRE and 2D-MRE for Assessing Cirrhosis and Portal Hypertension
- 3D-MRE for Assessing Cirrhosis, Advanced Chronic Liver Disease and Portal Hypertension
- 3D1015 Injection for Patients With mCRPC
- 40 Hz Flickering for Insomnia in Parkinson's Disease
- 6-year Follow-up Data After the Berberine Intervention Trial
- 68Ga FAPI PET/CT Evaluation of Axillary Lymph Node Status After Neoadjuvant Therapy in Patients With Clinical Axillary Lymph Node Positive Breast Cancer
- 68Ga-AAZTA-NI-093 PET/CT: First-in-human Study
- 68Ga-P16-093 and 68Ga-PSMA-11 PET/CT Imaging in the Same Group of Primary Prostate Cancer Patients
- 68Ga-P3 PET/CT Imaging in Prostate
- 68Ga-PFA2 PET Imaging for the Diagnosis of Annexin A2-Positive Tumors
- 68Ga-PFD3 PET Imaging for the Diagnosis and Evaluation of Small Cell Lung Cancer
- 68Ga-PSMA-11 PET Imaging for Diagnosing Prostate Cancer, a Head-to-head Comparison With mpMRI
- 68Ga-RM26-RGD PET/CT Imaging in the GRPR and αvβ3 Positive Tumor Patients
- 68Ga-SorB PET/CT Imaging in Patients With Solid Tumors
- 68Ga-XACP3 PET/CT in Prostate Cancer
- 68Ga-grazytracer PET Assists in Diagnosing Pseudoprogression Following Immunotherapy in Lung Cancer.
- 7.0T Magnetic Resonance Imaging Study of Parkinson's Disease
- 99Tc-MDP Treatment for Knee Osteoarthritis
- 99mTc-MY6349 SPECT/CT Imaging in Trop2-positive Triple-negative Breast Cancer
- 99mTc-P137 SPECT/CT in Prostate Cancer
- 99mTc-QULIC-5-P1 SPECT Imaging in Patients With Prostate Cancer
- A 20-Year Follow-up of First Episode Psychosis: Longitudinal Effects of Early Treatment Strategies and Relapse
- A Bidirectional Cohort Study on Prophylactic Resection Surgery in Populations at Moderate-to-High Risk for Hereditary Ovarian Cancer
- A Bioequivalence Study of PP3M in Patients With Schizophrenia
- A Biomarker Exploratory Study of Dual Blockade of PD1/PDL1 and CTLA4 and Anti-angiogenic Therapy
- A Cell-free DNA Methylation Blood-Based Test for Biliary Tract Cancers Screening
- A Clinical Study Evaluating the Application of La Roche-Posay's New B5 Multi-Effect Soothing and Repairing Cream on Individuals With Facial Atopic Dermatitis
- A Clinical Study Evaluating the Pharmacokinetic Characteristics and Safety of AHB-137 Injection in Participants With Mild to Moderate Liver Dysfunction and Those With Normal Liver Function.
- A Clinical Study Exploring the Safety, Efficacy and Cell Metabolic Dynamics of Universal CD19 / 20 Car-t Cell Injection in Moderate to Severe Refractory Systemic Lupus Erythematosus
- A Clinical Study of 9MW2821 (and PD-1 Inhibitor) in Locally Advanced or Metastatic Triple-Negative Breast Cancer
- A Clinical Study of Association Between Postoperative Dyslipidemia and Organ Rejection in Transplant Patients
- A Clinical Study of CD19 CAR-T in Active Systemic Lupus Erythematosus
- A Clinical Study of CD19 Universal CAR-γδT Cells in Active Systemic Lupus Erythematosus
- A Clinical Study of CHT102 in MSLN-Positive Advanced Pancreatic Cancer
- A Clinical Study of Calderasib (MK-1084) and Other Treatments for Participants With Non-Small Cell Lung Cancer (MK-1084-007/KANDLELIT-007)
- A Clinical Study of Dual-Target, Universal CAR-T Cell Therapy for Refractory Systemic Lupus Erythematosus
- A Clinical Study of Gocatamig (MK-6070) and Infinatamab Deruxtecan (MK-2400) in People With Small Cell Lung Cancer (MK-6070-003)
- A Clinical Study of HRS-5765 in Healthy Participants
- A Clinical Study of HRS-6209 Combined With Other Treatment Regimens in Patients With Breast Cancer
- A Clinical Study of HRS-7156 in Healthy Participants
- A Clinical Study of HRS-7525 Tablets in Patients With Advanced Prostate Cancer
- A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
- A Clinical Study of Inhaled Nitric Oxide in Moderate-to-Severe Chronic Obstructive Pulmonary Disease
- A Clinical Study of Inhaled Nitric Oxide in Patients With Chronic Obstructive Pulmonary Disease
- A Clinical Study of JMT101 in Combination With Osimertinib Versus Osimertinib Alone as First-Line Treatment for Patients With Locally Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer (NSCLC) Harboring Epidermal Growth Factor Receptor (EGFR) Sensitive Mutations
- A Clinical Study of LM103 Injection in the Treatment of Advanced Solid Tumors
- A Clinical Study of MK-1045 in People With Lupus or Rheumatoid Arthritis (MK-1045-004)
- A Clinical Study of MK-1084 With Other Treatments for Non-small Cell Lung Cancer (MK-3475-01F)
- A Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers (MK-9999-02A)
- A Clinical Study of Neoadjuvant Treatment With TQB2102 for Injection for Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer
- A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)
- A Clinical Study of QLC5508 and/or QLH12016 in Combination With Other Anti-tumor Therapies in Subjects With Advanced Prostate Cancer
- A Clinical Study of SHR-4394 in Combination With Anti-tumor Therapy in Prostate Cancer
- A Clinical Study of SPH5030 Tablets in the Treatment of Her2-positive/Mutated Biliary Tract OR Colorectal Cancer Patients.
- A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
- A Clinical Study of Sorafenib Combined With Gefitinib for the Treatment of pNET
- A Clinical Study of T3011 in Subjects With Advanced Melanoma
- A Clinical Study of TI-0032-III Injection in Patients With Relapsed and Refractory Autoimmune Diseases
- A Clinical Study of TQB2102 Versus Docetaxel Plus Trastuzumab and Pertuzumab in the Treatment of HER2 Positive Recurrent or Metastatic Breast Cancer
- A Clinical Study of TQB2450 Injection Combined With Chemotherapy or Anlotinib Hydrochloride Capsule in the Treatment of Non Small Cell Lung Cancer
- A Clinical Study of YTS109 Cell for R/R Autoimmune Diseases
- A Clinical Study of YTS109 Cell in R/R Autoimmune Diseases
- A Clinical Study of YTS109 Cell in R/R Systemic Lupus Erythematosus
- A Clinical Study of YTS109 Cells for the Treatment of R/R Autoimmune Diseases
- A Clinical Study of [68Ga]Ga-ELI421 Injection PET Imaging in Patients With Prostate Cancer
- A Clinical Study on the Effect of Cardiopulmonary Function and Quality of Life in Patients With Acute Coronary Syndrome Complicated by Heart Failure by "Lying-Sitting-Standing" Sequential Baduanjin
- A Clinical Study on the Efficacy and Safety of Fasudil Hydrochloride Combined With Immunotherapy in the Treatment of Metastatic Castration-resistant Prostate Cancer
- A Clinical Study on the Efficacy and Safety of Zonisamide as a First Add-On Treatment in Epileptic Seizures
- A Clinical Study on the First-line Treatment of Metastatic Pancreatic Cancer With TQB2916 Injection Combined With Gemcitabine Hydrochloride for Injection and Paclitaxel for Injection (Albumin-bound Type)
- A Clinical Study to Evaluate Efficacy and Safety of Serplulimab（HLX10） Combined With Bevacizumab（HLX04) and Chemotherapy (XELOX) in Patients With Metastatic Colorectal Cancer (mCRC)
- A Clinical Study to Evaluate SM17 for Atopic Dermatitis
- A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
- A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
- A Clinical Study to Evaluate the Efficacy and Safety of D-2570 in the Treatment of Moderate to Severe Plaque Psoriasis
- A Clinical Study to Evaluate the Efficacy and Safety of HRS9531 Tablets in Overweight or Obese Subjects
- A Clinical Study to Evaluate the Pharmacokinetic and Pharmacodynamics Properties of of SHR-3167 in Subjects With Type 2 Diabetes
- A Clinical Study to Evaluate the Safety and Tolerability of AWT020 in Patients With Advanced Malignancies
- A Clinical Study to Evaluate the Safety, Tolerability and Efficacy of BBM-A101 in the Treatment of Knee Osteoarthritis.
- A Clinical Study to Evaluate the Safety, Tolerability and Pharmacokinetic Profile of TQC3302 Inhalation Spray in Healthy Adult Subjects
- A Clinical Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of [225Ac]Ac-PSMA-XT Injection in Patients With Metastatic Castration-resistant Prostate Cancer
- A Clinical Study to Evaluate the Safety, and Tolerability of BBM-P002 in the Treatment of Parkinson's Disease
- A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung Cancer
- A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors
- A Clinical Trial Comparing Long-Course Versus Short-Course Radiotherapy Followed by Immunotherapy Combined With Total Neoadjuvant Therapy (TNT) to Long-Course Radiotherapy Followed by TNT in Locally Advanced Rectal Cancer
- A Clinical Trial Evaluating TQF3250 Capsules in Patients With Type 2 Diabetes Mellitus and Overweight/Obesity
- A Clinical Trial Evaluating the Safety and Efficacy of Intravenous HNF4α SrRNA in Treating Metastatic CRC Patients
- A Clinical Trial Evaluating the Safety and Tolerability, Biodistribution and Radiation Dosimetry, and Pharmacokinetics of Flotufolastat F-18 Injection in Healthy Chinese Adults
- A Clinical Trial Targeting CEA Chimeric Antigen Receptor T (CAR-T) for CEA Positive Advanced Malignant Solid Tumors
- A Clinical Trial Testing the Safety of Pumitamig (an Investigational Drug) and How Well it Works When Combined With Chemotherapy for People Who Have Not Been Treated Yet for Pancreatic Cancer
- A Clinical Trial of CEA Targeting CAR-T for CEA Positive Advanced Lung Cancer
- A Clinical Trial of Calderasib (MK-1084) and Durvalumab in People With Non-Small Cell Lung Cancer (MK-1084-015/KANDLELIT-015)
- A Clinical Trial of Parkinson's Disease Treatment by HiPSCs Derived Dopaminergic Neural Precursor Cells
- A Clinical Trial of SHR-A1811 in the Treatment of Triple-negative Breast Cancer
- A Clinical Trial of TQB2102 for Injection in Non-small Cell Lung Cancer With HER2 Gene Abnormality
Showing 100 of 3,909 recruiting trials.
Common questions
How many clinical trials are recruiting in China?
3,909 recruiting trials have at least one study site in China.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.